Initiating angiotensin converting enzyme inhibitors in mild to moderate heart failure in general practice: Randomised, placebo controlled trial

British Medical Journal

Volumn 317, Issue 7169, 1998, Pages 1352-1353

  Lough, Murray ^a   Cleland, John ^b   Langan, John ^c   Cowley, Alan ^d   Wade, Alan ^e  

^a Airdrie Health Centre   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c Bailleston Health Centre   (United Kingdom)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e Physiotherapy Department   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; QUINAPRIL;

ARTICLE; BLOOD CHEMISTRY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; GENERAL PRACTICE; HEART FAILURE; HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0032517504     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.317.7169.1352     Document Type: Article

References (7)

1. Mair FS, Crowley TS, Bundred PE. Prevalence, actiology and management of heart failure in general practice. Br J Gen Pract 1996;46:77-9.
2. Clarke KW, Gray D, Hampton JR. Evidence of inadequate investigation and treatment of patients with heart failure. Br Heart J 1994;71:584-7.
3. Houghton AR, Cowsley AJ. Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practiotioners. Int J Cardiol 1997;59:7-10.
4. Cleland JGF. ACE inhibitors for the prevention and treatment of heart failure: why are they 'under-used'? J Hum Hypertens 1995;9:435-42.
5. Cleland JGF, Ward S, Dutka D, Habib F, Impallomeni M, Morton IJ. Stability of plasma concentrations of N and C terminal atrial natriuretic peptides at room temperature. Heart 1996;75:410-3.
6. Anderson JV, Woodruff PWRB, Bloom SR. The effect of treatment of congestive heart failure on plasma atrial natriuretic peptide concentration: longitudinal study. Br Heart J 1987;57:578-9.
7. McDonagh TA, Robb SD, Morrison CE, Morton JJ, Tunstall-Pedoe H, McMurray JJ, et al. Natriuretic peptides as screening tools for left ventricular dysfunction [abstract]. Eur Heart J 1996;17(suppl):317.